Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy
Voss, M. H., Hakimi, A. A., Pham, C. G., Brannon, A. R., Chen, Y.-B., Cunha, L. F., Akin, O., Liu, H., Takeda, S., Scott, S. N., Socci, N. D., Viale, A., Schultz, N., Sander, C., Reuter, V. E., Russo,Volume:
20
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-13-2345
Date:
April, 2014
File:
PDF, 708 KB
english, 2014